These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9304668)

  • 1. Mutuality and solidarity: assessing risks and sharing losses.
    Wilkie D
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1039-44. PubMed ID: 9304668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic information and insurance: some ethical issues.
    O'Neill O
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1087-93. PubMed ID: 9304675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to value-based insurance design.
    Kelly AM; Cronin P; Carlos RC
    J Am Coll Radiol; 2008 Nov; 5(11):1118-24. PubMed ID: 18954811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covered but still at risk: how can policymakers address increased cost sharing in private health insurance?
    Rochefort DA; Ganim M; Donnelly KP
    Med Health R I; 2008 Apr; 91(4):109-10, 112. PubMed ID: 18595589
    [No Abstract]   [Full Text] [Related]  

  • 6. Out with the old, in with the young: lifetime community rating.
    Hindle D
    Aust Health Rev; 1999; 22(1):156-60. PubMed ID: 10387898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the assets of uninsured households to cost sharing under high-deductible health plans.
    Jacobs PD; Claxton G
    Health Aff (Millwood); 2008; 27(3):w214-21. PubMed ID: 18413333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing insurers' access to genetic information: genetic privacy, ignorance, and injustice.
    Feiring E
    Bioethics; 2009 Jun; 23(5):300-10. PubMed ID: 18410459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health insurance system in the Republic of Macedonia.
    Donev DM
    Croat Med J; 1999 Jun; 40(2):175-80. PubMed ID: 10234059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplemental health insurance: did Croatia miss an opportunity?
    Langenbrunner JC
    Croat Med J; 2002 Aug; 43(4):403-7. PubMed ID: 12187517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconsidering the moral hazard-risk avoidance tradeoff.
    Newhouse JP
    J Health Econ; 2006 Sep; 25(5):1005-14. PubMed ID: 16860893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk sharing--the crossroad of interest between providers and benefit financing entities.
    Barth S
    Health Care Strateg Manage; 1987 Dec; 5(12):4-9. PubMed ID: 10285684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funding long-term care by applying the trade-off principle to public and private insurance.
    Chen YP
    Policy Brief (Cent Home Care Policy Res); 2003; (17):1-4. PubMed ID: 15011650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal rules and industry norms: the impact of laws restricting health insurers' use of genetic information.
    Hall MA
    Jurimetrics; 1999; 40(1):93-122. PubMed ID: 12737178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards advanced risk-sharing in health care financing: with a focus on the potential of social health insurance in developing countries.
    Carrin G
    Verh K Acad Geneeskd Belg; 2004; 66(3):215-34; discussion 234-6. PubMed ID: 15315121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing in competitive insurance markets with repulsion from chance: a welfare analysis.
    Hoel M; Iversen T; Nilssen T; Vislie J
    J Health Econ; 2006 Sep; 25(5):847-60. PubMed ID: 16442646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance.
    Homsma SJ; Huijgen R; Middeldorp S; Sijbrands EJ; Kastelein JJ
    Eur J Hum Genet; 2008 Jan; 16(1):14-7. PubMed ID: 17957228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit design innovations: implications for consumer-directed health care.
    Tu HT; Ginsburg PB
    Issue Brief Cent Stud Health Syst Change; 2007 Feb; (109):1-6. PubMed ID: 17312626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal health insurance for prevention and treatment.
    Ellis RP; Manning WG
    J Health Econ; 2007 Dec; 26(6):1128-50. PubMed ID: 17997176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.